1. American thoracic society: guidelines for the management of adultswith hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005;171(4):388-416.
2. Seligman R, Meisner M, Lisboa T, et al. Decreases in procalcitoninand C-reactive protein are strong predictors of survival in ventilator-associated pneumonia. Crit Care. 2006; 10(5):1-9.
3. Kılınç O, Arman D, Bacakoğlu F, et al. Türk Toraks Derneğierişkinlerde hastanede gelişen pnömoni tanı ve tedavi uzlaşı raporu.Türk Toraks Derg. 2009;10(6):1-24.
4. Türk Toraks Derneği Erişkinlerde Hastanede Gelişen Pnömoni Tanı VeTedavi Uzlaşı Raporu. Türk Toraks Dergisi. 2018;p1.
5. Pugin J, Auckenthaler R, Mili N, Janssens JP, Lew PD, Suter PM.Diagnosis of ventilator-associated pneumonia by bacteriologic analysisof bronchoscopic and nonbronchoscopic “blind” bronchoalveolarlavage fluid. Am Rev Respir Dis. 1991;143(5 Pt 1):1121-1129.
6. Akalın H, Özakın C, Kahveci F, et al. Hastanede gelişen pnömoniler.Flora. 1999;4:253-257.
7. Tablan OC, Anderson LJ, Besser R, et al. Guidelines for preventinghealth-care-associated pneumonia, 2003: recommendations of CDCand the Healthcare Infection Control Practices Advisory Committee.MMWR Recomm Rep. 2004;53(RR-3):1-36.
8. Fortaleza CM, Abati PA, Batista MR, Dias A. Risk factors for hospital-acquiredpneumonia in nonventilated adults. Braz J Infect Dis. 2009;13(4):284-288.
9. Kalil AC, Metersky ML, Klompas M, et al. Management of adults withhospital-acquired and ventilator-associated pneumonia: 2016 clinicalpractice guidelines by the infectious diseases society of America andthe American thoracic society. Clin Infect Dis. 2016;63(5):e61-e111.
10. DiPasquale M, Aliberti S, Mantero M, et al. Non-intensive care unitacquired pneumonia: a new clinical entity? Int J Mol Sci. 2016;17(3):287.
11. Dandagi GL. Nosocomial pneumonia in critically ill patients. LungIndia. 2010;27(3):149-153. doi:10.4103/0970-2113.68321
12. Gastmeier P, Sohr D, Geffers C, Behnke M, Rüden H. Risk factorsfor death due to nosocomial infection in intensive care unit patients:findings from the Krankenhaus Infektions Surveillance System. InfectControl Hosp Epidemiol. 2007;28(4):466-472.
13. Napolitano LM. Use of severity scoring and stratification factorsin clinical trials of hospital-acquired and ventilator-associatedpneumonia. Clin Infect Dis. 2010;51(1):S67-S80.
14. Domínguez AA, Arango MV, Torres A. Treatment failure in patientswith ventilator-associated pneumonia. Semin Respir Crit Care Med.2006;27(1):104-114.
15. Vallés J, Mesalles E, Mariscal D, et al. A 7-year study of severe hospital-acquired pneumonia requiring ICU admission. Intensive Care Med.2003;29(11):1981-1988.
16. Deng Z, Hu BJ, He LX, et al. A multicenter prospective cohort study onrisk factors for hospital-acquired pneumonia in the elderly. ZhonghuaNei Ke Za Zhi. 2008;47(1):31-35.
17. Hilker R, Poetter C, Findeisen N, et al. Nosocomial pneumonia afteracute stroke: implications for neurological intensive care medicine.Stroke. 2003;34(4):975-981.
18. Shorr AF, Cook D, Jiang X, Muscedere J, Heyland D; Canadian CriticalCare Trials Group. Correlates of clinical failure in ventilator-associatedpneumonia: insights from a large, randomized trial. J Crit Care. 2008;23(1):64-73.
19. Luna CM, Blanzaco D, Niederman MS, et al. Resolution of ventilator-associated pneumonia: prospective evaluation of the clinical pulmonaryinfection score as an early clinical predictor of outcome. Crit Care Med.2003;31(3):676-682.
20. Swoboda SM, Dixon T, Lipsett PA. Can the clinical pulmonary infectionscore impact ICU antibiotic days? Surg Infect (Larchmt). 2006;7(4):331-339.
21. Sathitakorn O, Chansirikarnjana S, Jantarathaneewat K, et al. Therole of procalcitonin and clinical pulmonary for infection score(CPIS) score to reduce inappropriate antibiotics use among moderateto severe coronavirus disease 2019 (COVID-19) pneumonia: aquasi-experimental multicenter study. Infection Control & HospitalEpidemiology. 2023;44(7):1199-1203.
22. Vincent JL, Rello J, Marshall J, et al. International study of theprevalence and outcomes of infection in intensive care units. JAMA.2009;302(21):2323-2329.
23. Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J. Serumprocalcitonin and C-reactive protein levels as markers of bacterialinfection: a systematic review and meta-analysis. Clin Infect Dis.2004;39(2):206-217.
24. Holm A, Pedersen SS, Nexoe J, et al. Procalcitonin versus C-reactiveprotein for predicting pneumonia in adults with lower respiratory tractinfection in primary care. Br J Gen Pract. 2007;57(540):555-560.
25. Zheng N, Zhu D, Han Y. Procalcitonin and C-reactive protein performbetter than the neutrophil/lymphocyte count ratio in evaluatinghospital acquired pneumonia. BMC Pulm Med. 2020;20(1):1-10.
26. Ramirez P, Garcia MA, Ferrer M, et al. Sequential measurements ofprocalcitonin levels in diagnosing ventilator-associated pneumonia.Eur Respir J. 2008;31(2):356-362.
27. Lim SC, Doshi V, Castasus B, Lim JK, Mamun K. Factors causing delayin discharge of elderly patients in an acute care hospital. Ann Acad MedSingap. 2006;35(1):27-32.